Cytoskeleton-associated protein 4 (CKAP4), which has been linked to worse outcomes in several types of cancer, has emerged as a novel biomarker to predict patient outcomes for bladder cancer following radical cystectomy. This evidence concerns the gene CKAP4 and urinary bladder cancer.